Literature DB >> 11442327

Spinal muscular atrophy.

K Talbot1, K E Davies.   

Abstract

The spinal muscular atrophies are a group of mostly inherited disorders selectively affecting the lower motor neuron. There is a wide degree of clinical and genetic heterogeneity that must be taken into account when giving prognostic information. Autosomal recessive childhood proximal SMA is the commonest form and is due to mutations in a gene encoding a novel protein, SMN, that appears to play a critical role in RNA metabolism but has also been shown to interact with actin-binding proteins and mediators of programmed cell death. The identification of the genetic basis of SMA has resulted in advances for prenatal diagnosis and in new insights into motor neuron biology. The chromosomal location of two of the rarer dominant forms of SMA has been found. Identification of the molecular pathophysiology of lower motor neuron syndromes can be expected to aid in the development of therapy for these disabling disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442327     DOI: 10.1055/s-2001-15264

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  25 in total

1.  Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein.

Authors:  M D Hebert; P W Szymczyk; K B Shpargel; A G Matera
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 2.  The role of CELF proteins in neurological disorders.

Authors:  Jean-Marc Gallo; Carl Spickett
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 3.  Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy.

Authors:  Rachel Nlend Nlend; Kathrin Meyer; Daniel Schümperli
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

4.  An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival.

Authors:  John C Fyfe; Marilyn Menotti-Raymond; Victor A David; Lars Brichta; Alejandro A Schäffer; Richa Agarwala; William J Murphy; William J Wedemeyer; Brittany L Gregory; Bethany G Buzzell; Meghan C Drummond; Brunhilde Wirth; Stephen J O'Brien
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

5.  SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.

Authors:  Mohini Jangi; Christina Fleet; Patrick Cullen; Shipra V Gupta; Shila Mekhoubad; Eric Chiao; Norm Allaire; C Frank Bennett; Frank Rigo; Adrian R Krainer; Jessica A Hurt; John P Carulli; John F Staropoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 6.  Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy.

Authors:  Alessandra Govoni; Delia Gagliardi; Giacomo P Comi; Stefania Corti
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

7.  A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity.

Authors:  Sungchan Cho; Gideon Dreyfuss
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

8.  Electrophysiological properties of motor neurons in a mouse model of severe spinal muscular atrophy: in vitro versus in vivo development.

Authors:  Hongmei Zhang; Natallia Robinson; Chiayen Wu; Wenlan Wang; Melissa A Harrington
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

9.  Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.

Authors:  Graham C Parker; Xingli Li; Roumen A Anguelov; Gabor Toth; Adam Cristescu; Gyula Acsadi
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

Review 10.  Motor neurone disease.

Authors:  K Talbot
Journal:  Postgrad Med J       Date:  2002-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.